Phase 1 Anorexia Nervosa Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Not Yet Recruiting
Phase 1
Testing the Safety and Effects of the Psychedelic Psilocin on Wellbeing and Anxiety in People with Ongoing Physical and Mental Health Conditions
Chronic Fatigue SyndromeAnorexia NervosaFibromyalgia+6 more
Tryptamine Therapeutics66 enrolled1 locationACTRN12625000949482
Recruiting
Phase 1
tDCS and Cognitive Training for Restrictive Eating Disorders
Anorexia NervosaAtypical Anorexia Nervosa
University of Minnesota20 enrolled1 locationNCT06624150
Recruiting
Phase 1
Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder
Anorexia Nervosa (DSM-IV Revised Criteria)
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT07113665
Recruiting
Phase 1
A clinical trial of psilocybin-assisted psychotherapy for treatment-resistant anorexia nervosa
Anorexia Nervosa
University of Sydney30 enrolled1 locationACTRN12623000357651
Completed
Phase 1
The Effect of Oxytocin on Cognitive Rigidity and Social Anxiety in Eating Disorders
Anorexia Nervosa
The Centre for Eating and Dieting Disorders (CEDD)80 enrolled1 locationACTRN12611000671965